Literature DB >> 28467874

Crizanlizumab in Sickle Cell Disease.

Kenneth I Ataga1, Abdullah Kutlar2, Julie Kanter3.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28467874     DOI： 10.1056/NEJMc1703162

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Gene therapy for sickle cell disease: where we are now?

Authors:  Julie Kanter; Corey Falcon
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

2.  The gut microbiome in sickle cell disease: Characterization and potential implications.

Authors:  Hassan Brim; James Taylor; Muneer Abbas; Kimberly Vilmenay; Mohammad Daremipouran; Sudhir Varma; Edward Lee; Betty Pace; Waogwende L Song-Naba; Kalpna Gupta; Sergei Nekhai; Patricia O'Neil; Hassan Ashktorab
Journal:  PLoS One       Date:  2021-08-25       Impact factor: 3.240

3.  Factor H interferes with the adhesion of sickle red cells to vascular endothelium: a novel disease-modulating molecule.

Authors:  Elisabetta Lombardi; Alessandro Matte; Antonio M Risitano; Daniel Ricklin; John D Lambris; Denise De Zanet; Sakari T Jokiranta; Nicola Martinelli; Cinzia Scambi; Gianluca Salvagno; Zeno Bisoffi; Chiara Colato; Angela Siciliano; Oscar Bortolami; Mario Mazzuccato; Francesco Zorzi; Luigi De Marco; Lucia De Franceschi
Journal:  Haematologica       Date:  2019-01-10       Impact factor: 9.941

Review 4.  Sickle cell disease: a review for the internist.

Authors:  Valeria Maria Pinto; Manuela Balocco; Sabrina Quintino; Gian Luca Forni
Journal:  Intern Emerg Med       Date:  2019-08-05       Impact factor: 5.472

Review 5.  Why, Who, When, and How? Rationale for Considering Allogeneic Stem Cell Transplantation in Children with Sickle Cell Disease.

Authors:  Françoise Bernaudin
Journal:  J Clin Med       Date:  2019-09-22       Impact factor: 4.241

Review 6.  Life-Threatening Infectious Complications in Sickle Cell Disease: A Concise Narrative Review.

Authors:  Dominik Ochocinski; Mansi Dalal; L Vandy Black; Silvana Carr; Judy Lew; Kevin Sullivan; Niranjan Kissoon
Journal:  Front Pediatr       Date:  2020-02-20       Impact factor: 3.418
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.